GlassScriptPhysician profile
Elyse P Erlich
NPI 1952371536
$5,657.05
in general payments reported to CMS, 2019-2025
52 companies · $609 in 2025
The $609 reported for 2025 was more than what 79% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $423 · 2021: $1,879 · 2022: $853 · 2023: $717 · 2024: $764 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,090.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $1,017.37 | 2021 | |
| Abbvie INC. | $501.98 | 2019-2024 | |
| Hologic Sales and Service, LLC | $366.87 | 2019-2025 | Myosure Tissue Removal Device, Aptima, Acessa Provu System |
| Organon LLC | $363.42 | 2021-2025 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $253.77 | 2019-2025 | Slynd |
| Shield Therapeutics INC | $233.68 | 2023-2024 | Accrufer |
| Mayne Pharma Commercial LLC | $218.26 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $216.13 | 2023-2025 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $202.97 | 2019-2022 | |
| Coopersurgical, INC. | $178.11 | 2019-2025 | Paragard T 380a, Summit Doppler |
| Astellas Pharma US INC | $170.74 | 2019-2025 | Veozah |
| Aspira Women'S Health INC | $159.30 | 2021-2022 | |
| Pfizer INC. | $157.84 | 2019-2024 | |
| Myovant Sciences INC. | $127.87 | 2021-2022 | |
| Radius Health, INC. | $120.83 | 2023-2024 | Tymlos |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elyse Erlich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.